EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy

Katharina Knoll iD, Patrick Fuchs, Isabel Weidmann, Fatih Altunkas, Stephanie Voss, Carsten Lennerz, Christof Kolb, Thorsten Kessler, Heribert Schunkert iD, Wibke Reinhard, Stefan Groß iD, Teresa Trenkwalder

Journal of Clinical Medicine · 11.07.2023 · 12 (14) · 4624

DOI: 10.3390/jcm12144624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.07.2023. Verfasst von Katharina Knoll und 11 weiteren Autor:innen. Beteiligte Einrichtung: German Heart Centre Munich, Department of Cardiology, Technical University of Munich, 80333 Munich, Germany. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer (Germany), the Philipp Schwartz Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Wild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is characterized by heart failure, conduction abnormalities and arrhythmias. The incidence of ventricular arrhythmias, particularly ventricular tachycardias (VTs), in wtATTR-CM is unclear. With the development of targeted therapies and improved overall prognosis, there is an unmet need to identify patients at high risk for VTs who might benefit from ICD therapy.

Methods

Between 2017 and 2022, 72 patients diagnosed with wtATTR-CM were prospectively evaluated for the presence of ventricular arrhythmias using a Holter ECG. VTs were defined as >3 consecutive beats with a heart rate > 100 beats per minute originating from a ventricle.

Results

The incidence of VTs was 44% (n = 32/72) in unselected wtATTR-CM patients. Patients with VT showed significantly more severe left ventricular (LV) hypertrophy (septum diameter 21 ± 2.6 vs. 19 ± 3.0 mm, p = 0.006), reduced LV ejection fraction (47 ± 8 vs. 52 ± 8%, p = 0.014) and larger left atria (32 ± 7 vs. 28 ± 6 mm2, p = 0.020), but no differences in cardiac markers such as NTproBNP and troponin. In a multivariable model, LV hypertrophy (LV mass indexed, OR = 1.02 [1.00–1.03], p = 0.031), LV end-diastolic diameter (OR = 0.85 [0.74–0.98], p = 0.021) and LV end-systolic diameter (OR = 1.19 [1.03–1.349], p = 0.092) were predictive for VT occurrence with an area under the receiver operating characteristic of 0.76 [0.65–0.87].

Conclusions

The incidence of ventricular arrhythmia in wtATTR-CM is high and is associated with an advanced stage of left ventricular disease. Further studies are needed evaluating the role of VTs in predicting sudden cardiac death and the benefit of ICD therapy in wtATTR-CM.

Schlagwörter

Stichwörter der Autor:innen

amyloidosiscardiomyopathytransthyretinventricular arrhythmiaventricular tachycardia

Autor:innen und Institutionen

  • German Heart Centre Munich, Department of Cardiology, Technical University of Munich, 80333 Munich, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, 80336 Munich, Germany.
  • German Heart Centre Munich, Department of Cardiovascular Surgery, Technical University of Munich, 80636 Munich, Germany.
  • DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, 17475 Greifswald, Germany.
  • Department of Internal Medicine B, University Medicine Greifswald, 17475 Greifswald, Germany.

ORCID-Profile: Katharina Knoll, Heribert Schunkert, Stefan Groß

Förderung

  • Pfizer (Germany)
  • the Philipp Schwartz Initiative

Zitieren

APA

Knoll, K., Fuchs, P., Weidmann, I., Altunkas, F., Voss, S., Lennerz, C., Kolb, C., Kessler, T., Schunkert, H., Reinhard, W., Groß, S., & Trenkwalder, T. (2023). Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy. Journal of Clinical Medicine, 12(14), 4624. https://doi.org/10.3390/jcm12144624

Vancouver

Knoll K, Fuchs P, Weidmann I, Altunkas F, Voss S, Lennerz C, et al. Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy. Journal of Clinical Medicine. 2023;12(14):4624. doi:10.3390/jcm12144624

BibTeX
@article{Knoll2023,
  author = {Knoll, Katharina and Fuchs, Patrick and Weidmann, Isabel and Altunkas, Fatih and Voss, Stephanie and Lennerz, Carsten and Kolb, Christof and Kessler, Thorsten and Schunkert, Heribert and Reinhard, Wibke and Groß, Stefan and Trenkwalder, Teresa},
  title = {Incidence and Predictors of Ventricular Arrhythmias in Transthyretin Amyloid Cardiomyopathy},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {14},
  pages = {4624},
  doi = {10.3390/jcm12144624}
}
Kostenlos starten →